Marianna Lalla

Phase 1/1b Studies of <scp>UCB0599</scp>, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Johan W. Smit, Peter Basile, Maria Key Prato et al. · Movement Disorders · 2022 · 58 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

Elisabeth De Leeuw, Karel Van Damme, Jozefien Declercq et al. · Respiratory Research · 2022 · 22 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Evaluation and Application of a PET Tracer in Preclinical and Phase 1 Studies to Determine the Brain Biodistribution of Minzasolmin (UCB0599)

Joël Mercier, Massimo Bani, Anny‐Odile Colson et al. · Molecular Imaging and Biology · 2023 · 11 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +15